Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trialMarius Trøseid, Alpha Diallo, José Ramón Arribas et al.|Critical Care|2023Cited by 47
Staged, bilateral MR-guided focused ultrasound of the pallidothalamic tract in Parkinson’s disease: a phase III studyHarini Sarva, Ari Grinspan, W.C. Chang et al.|Parkinsonism & Related Disorders|2025Cited by 0